The Whisper Becomes a Roar: Why Novartis Needs Avidity’s RNA Revolution, Now More Than Ever

The Biotech Gambit: Novartis Reportedly Eyes Avidity in a High-Stakes Acquisition

The Big Pharma Buzz: Why Novartis Might Be Eyeing Avidity's RNA Magic

FDA Unleashes Game-Changing Incentive: Priority Review Vouchers Set to Revolutionize Drug Development

Baby KJ's Milestone: Unlocking Personalized CRISPR Gene Editing for the Masses

Monopar's Breakthrough in Wilson Disease: A New Dawn with AstraZeneca's Shadow

Biohaven's Breakthrough Bid: Navigating FDA Flexibility for Spinocerebellar Ataxia's Future

Baby KJ's Miraculous CRISPR Journey: A New Dawn for Personalized Gene Editing

The High-Stakes Battle Over Elevidys: Efficacy, Ethics, and the Future of Rare Disease Drugs

A Mother's Unwavering Intuition: The Rare Diagnosis of Cockayne Syndrome

PGI Chandigarh Unlocks Future of Paediatric Care with Next-Gen Genetic Sequencing Facility

The Boy Who Stopped Time: Oliver's Battle Against a Rare Tumor That Halted His Growth at 12

The Unprecedented Life of the World's Oldest Progeria Survivor

Harmony Bio Faces Significant Setback: Fragile X Syndrome Therapy Misses Primary Endpoint in Pivotal Trial

Pioneering Partnership: GCCL and Frontage Laboratories Unite to Revolutionize Global Clinical Trials

European Experts Back Two AstraZeneca Breakthroughs: New Hope for Rare Diseases

A New Frontier in Medicine: FDA's Groundbreaking Stance on Gene-Editing Therapies for Rare Diseases

New Jersey Ignites Biotech Revolution with Cutting-Edge Gene Therapy Hub, Bringing Hope and High-Tech Jobs

Navigating the Path to Approval: Why REGENXBIO (RGNX) Remains a Strong Investment with RGX-121 for Hunter Syndrome

A Beacon of Hope: Healthcare Industry Applauds Potential GST Reduction on Life-Saving Drugs and Medical Devices

Unlocking Health Futures: The Indispensable Role of Medical Registries in Research and Policy

A Call for Justice: Huntington's Disease Patients Demand Inclusion in National Rare Diseases Policy

Crisis at America's Research Hospital: Patient Numbers Plummet at NIH Under Trump, Jeopardizing Vital Care and Medical Breakthroughs

Crisis at the Forefront of Medical Innovation: NIH Patient Numbers Plummet, Threatening Critical Research and Care

Rocket Soars: Why Rocket Pharmaceuticals Stock Just Exploded Over 15%!

Walgreens Supercharges Specialty Pharmacy Network Amid Surging Demand for Life-Changing Therapies

Intermountain Primary Children’s: Pioneering Personalized Medicine for Kids